India's medical device company BPL Medical Technologies Pvt. Ltd., or BPL, said on Jan. 29 it has completed the acquisition of South Korean medical device company YozmaBMTech.

The transaction was an M&A deal carried out before approval during rehabilitation proceedings. BPL participated in YozmaBMTech through a new-share investment, securing management control.

After applying for rehabilitation proceedings in August 2024, YozmaBMTech went through step-by-step procedures including selecting an acquisition candidate and signing an investment agreement. The acquisition was finally confirmed following the Seoul Rehabilitation Court's decision on Dec. 29, 2025 to end the rehabilitation process.

BPL is a medical device manufacturer headquartered in Bengaluru, India. It began its medical device business in 1967 by producing India's first electrocardiogram (ECG) device. Since launching as an independent corporation in 2013, it has operated manufacturing facilities in Palakkad and Bengaluru, producing and supplying core hospital medical devices including ECGs, patient monitoring systems, ventilators, X-ray machines and anaesthesia workstations.

YozmaBMTech is a specialised medical device company focused on bone densitometers and aesthetic medical devices. Through the acquisition, BPL plans to expand its business by linking YozmaBMTech's bone density diagnostic solutions and aesthetic medical device technology with its existing diagnostic imaging and women's health portfolio.

BPL Chief Executive Sunil Khurana (수닐 쿠라나) said the acquisition was a strategic decision to complement BPL's product portfolio and strengthen competitiveness in its medical device business. He said the company will focus on supplying stable and efficient medical solutions to medical sites around the world by combining the two companies' manufacturing technology and global distribution capabilities.